Palomino Laboratories (PALX) Operating Expenses (2023 - 2025)
Palomino Laboratories recorded quarterly Operating Expenses of -$1.9 million in Q4 2025, down 220.27% quarter-over-quarter from $1.6 million in Q3 2025, and down 1499.08% year-over-year from $137962.0 in Q4 2024.
Palomino Laboratories' Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.9 million for Q4 2025.
- In Q4 2025, Operating Expenses fell 1499.08% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at -$271897.0 (down 222.32% YoY), while the FY2025 annual figure was $30000.0, down 78.58% from the prior year.
- Operating Expenses came in at -$1.9 million for Q4 2025 at Palomino Laboratories, down from $1.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2025.
- A 3-year average of $2860.9 and a median of $32182.5 in 2023 frame the typical range for Operating Expenses.
- On a YoY basis, Operating Expenses climbed as much as 129958.51% in 2025 and fell as far as 1499.08% in 2025.
- Palomino Laboratories' Operating Expenses stood at $32574.0 in 2023, then surged by 323.53% to $137962.0 in 2024, then sank by 1499.08% to -$1.9 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered -$1.9 million, $1.6 million, and $35548.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 35,548.00 |
| Mar 31, 2025 | 53,525.00 |
| Dec 31, 2024 | 137,962.00 |
| Sep 30, 2024 | 1,234.00 |
| Jun 30, 2024 | 31,791.00 |
| Mar 31, 2024 | 51,304.00 |
| Dec 31, 2023 | 32,574.00 |
| Sep 30, 2023 | 42,863.00 |
| Jun 30, 2023 | 4,250.00 |
| Mar 31, 2023 | 4,250.00 |